10 completed. 10 Phase 3.
By phase and status
Follow Helping Behavior: new trials by email Literature Review of Helping Behavior trials Research Report on Helping Behavior
Trials (filtered) newest first · largest first
All 10 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility | Phase 3 | Completed | 939 | 2014-01-31 | 2017-08-24 |
"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care." ASSIST-linked brief intervention for hazardous and harmful substance use., Observation - Alcohol-Related Disorders, Substance-Related Disorders | Phase 3 | Completed | 400 | 2011-12-01 | 2013-10-09 |
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique Gonal-f®, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG) - Assisted Reproductive Techniques, Reproductive Technology, Assisted | Phase 3 | Completed | 202 | 2011-05-31 | 2021-05-28 |
Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031) Corifollitropin alfa, recFSH (follitropin beta) - Infertility | Phase 3 | Completed | 307 | 2010-06-02 | 2024-06-20 |
Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029) SCH 900962 / Corifollitropin alfa / Org 36286, RecFSH / follitropin beta, Placebo for SCH 900962 - Infertility | Phase 3 | Completed | 1424 | 2010-06-01 | 2022-02-03 |
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) ganirelix, triptorelin - Controlled Ovarian Stimulation | Phase 3 | Completed | 259 | 2007-05-01 | 2022-02-03 |
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women Gonalef® (Follitropin alfa), Purified pituitary gonadotropin (Fertinorm-P®) - Infertility, Ovulation Induction | Phase 3 | Completed | 300 | 2007-02-01 | 2013-12-27 |
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies Recombinant Human-Luteinizing Hormone (Luveris) - Infertility, Ovarian Stimulation | Phase 3 | Completed | 55 | 2004-09-01 | 2013-08-07 |
A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET) Micronised Progesterone, Progesterone - Infertility | Phase 3 | Completed | 238 | 2004-05-01 | 2014-07-31 |
A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET) r-hCG, Urinary-hCG - Infertility | Phase 3 | Completed | 218 | 2003-12-01 | 2014-07-31 |
Narrower conditions
Infertility (7) · Alcohol-Related Disorders (1) · Polycystic Ovary Syndrome (1) · Substance-Related Disorders (1)
Broader conditions
Behavior (10) · Social Behavior (10) · Genital Diseases (7) · Urogenital Diseases (7) · Adnexal Diseases (1) · Chemically-Induced Disorders (1) · Cysts (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases, Female (1) · Gonadal Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Ovarian Cysts (1)
Interventions
Chorionic Gonadotropin (3) · Ovidrel (3) · follitropin alfa (3) · follicle stimulating hormone, human, with HCG C-terminal peptide (2) · follitropin beta (2) · pergoveris (2) · Luteinizing Hormone, beta Subunit (1) · Observation (1) · Profasi (1) · Progesterone (1) · Triptorelin Pamoate (1) · Urofollitropin (1) · ganirelix (1)
Sponsors
Merck KGaA, Darmstadt, Germany (5) · Organon and Co (3) · EMD Serono (1) · Pontificia Universidad Catolica de Chile (1)
Countries
China (2) · Germany (2) · Chile (1) · Denmark (1) · Finland (1) · France (1) · Greece (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Russia (1) · Slovakia (1) · United Kingdom (1)
Top investigators
Huafei Li (2) · Fernando Poblete, MD, MPH (1) · Kimitoshi Takemura (1) · Salvatore Longobardi, MD (1)
Results publications
PMID 22429192, PMID 26003273, PMID 26141305, PMID 26194884, PMID 26520396, PMID 26991902, PMID 27090863, PMID 27619773, PMID 28137754, PMID 29699333, PMID 37158538